News By Tag
* Danforth Center
* St Louis
* 9 Billion
* More Tags...
News By Location
Plant Science Innovation: From Lab Bench to Dinner Plate
Danforth Center’s “Conversations” Series Continues Let’s talk… about Plant Science Innovation: From Lab Bench to Dinner Plate
The world’s population of 7 billion will grow over 9 billion by the year 2050, along with the growing dilemma of not enough food to go around. Plant science continues to evolve with the goal of full plates for an expanding global population by meeting challenges in agriculture, like producing plants that use far less water, or that resist emerging pests and diseases.
The panel will highlight how impactful research in the lab can meet the demands of a booming population by reaching small farmers and consumers with today’s technologies.
To join us for an enlightening discussion, reserve your spot today! Reservations are required but complimentary;
About the Speakers
Jan Jaworski, Ph.D., Principal Investigator, Donald Danforth Plant Science Center
Dr. Jarworski is a member and principal investigator at the Danforth Center. His research focuses on better understanding the pathways and enzymes in plants that are involved in lipid biosynthesis, including identifying genes responsible for producing unusual oils and those with potential industrial applications. Recently, his interest in the metabolic engineering of oil seeds expanded to include projects on the production of biofuels and biodegradable plastics.
Prior to joining the Center Dr. Jaworski was a professor and researcher in the Department of Chemistry and Biochemistry at Miami University in Oxford, Ohio for 27 years. Jaworski earned his B.A. in chemistry from the College of the Holy Cross in Worcester, Massachusetts and received his Ph.D. from Purdue University.
Brian L. Clevinger, Ph.D., Managing Director, Prolog Ventures, LLC
Dr. Clevinger is a founder and managing director of Prolog Ventures, a St. Louis based early stage, life science venture capital fund. He has actively participated in all phases of commercial technology development for nearly two decades. Before Prolog, he was the CEO of Megan Health, a vaccine developer. He held this position from Megan’s inception until its acquisition by AVANT Immunotherapeutics. Previously, Dr. Clevinger was the president of A/W Company, a technology transfer partnership of the private equity firm Alafi Capital and Washington University. Working with Washington University researchers, he evaluated numerous technologies, selected the most commercially promising ones for funding, and served on the board of each resulting enterprise. Before joining A/W Company, he held a tenured position and headed a research laboratory at Washington University. Dr. Clevinger holds a doctoral degree in immunology from Indiana University and was a NIH postdoctoral fellow at Washington University.
# # #
About The Donald Danforth Plant Science Center
Founded in 1998, the Donald Danforth Plant Science Center is a not-for-profit research institute with a mission to improve the human condition through plant science. Research at the Danforth Center will feed the hungry and improve human health, preserve and renew the environment, and enhance the St. Louis region and Missouri as a world center for plant science. The Center’s work is funded through competitive grants and contract revenue from many sources, including the National Institutes of Health, U.S. Department of Energy, National Science Foundation, U.S. Department of Agriculture, U.S. Agency for International Development and the Bill & Melinda Gates Foundation.
Follow us on Twitter at @DanforthCenter.